Cleared Traditional

K843285 - TRI-MED 610 CAPNOSTAT GAS ANALYZER

K843285 is the FDA 510(k) clearance for TRI-MED 610 CAPNOSTAT GAS ANALYZER by Tri-Med, Inc.. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K843285 · Tri-Med, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1984
Decision
84d
Days
Class 2
Risk

K843285 is an FDA 510(k) clearance for the TRI-MED 610 CAPNOSTAT GAS ANALYZER. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Tri-Med, Inc. (Redmond, US). The FDA issued a Cleared decision on November 13, 1984 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tri-Med, Inc. devices

Submission Details

510(k) Number K843285 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 21, 1984
Decision Date November 13, 1984
Days to Decision 84 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 140d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 147
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K843285.
TRI-MED MODEL 126 SAMPLE LINE W/EXTENDED LIFE NAFI
K850746 · Tri-Med, Inc. · Apr 1985
TRI-MED MODEL 105 SPECIAL AIRWAY ADAPTOR
K850747 · Tri-Med, Inc. · Apr 1985
CPNOGARD CAPNOMETER 1250
K844010 · Novametrix Medical Systems, Inc. · Feb 1985
MODEL IM1074 END-TIDAL CO2 MODULE
K843970 · Gould, Inc. · Oct 1984
CO2 TEST
K843844 · Erich Jaeger, Inc. · Oct 1984
OHMEDA MODEL 5200 CO2 MONITOR
K843599 · Ohmeda Medical · Oct 1984